Treatment for Completers of the Study B7A-MC-MBCM

Clinical trial NCT00266695 · COMPLETED

Trial details

NCT number: NCT00266695
Sponsor: Chromaderm, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Retinopathy

Start date: 2006-01-01
Primary completion: 2008-08-01
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.